Literature DB >> 22019969

Terson syndrome: an underrecognized cause of reversible vision loss in patients with subarachnoid hemorrhage.

Kim Middleton1, Peter Esselman, P Chuwn Lim.   

Abstract

Terson syndrome is a known complication of subarachnoid hemorrhage (SAH) that causes potentially reversible vision loss. It develops after SAH because of vitreous hemorrhage caused by retinal capillary disruption. Case series report an incidence of Terson syndrome in approximately 8%-15% of patients with SAH. Nonetheless, the medical literature regarding this condition is primarily found within neurosurgical and ophthalmologic journals with little mention within the rehabilitation medicine literature. Physiatrists must be aware of this clinical presentation to coordinate the care of patients with SAH who develop vision loss and develop a rehabilitation plan that addresses the co-morbid motor, sensory, and cognitive impairments. Physiatrists may be the first to identify visual loss, are well equipped to emphasize compensatory strategies, and are well positioned to coordinate surgical treatment for visual recovery in appropriate cases. In this report, we describe the case of a young woman with SAH and Terson syndrome through her acute hospital admission, rehabilitation treatment, ophthalmologic management, and outcome, describing the salient epidemiology, pathophysiology, diagnostic workup, and treatment options.

Entities:  

Mesh:

Year:  2012        PMID: 22019969     DOI: 10.1097/PHM.0b013e3182328792

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  2 in total

1.  Terson Syndrome in Aneurysmal Subarachnoid Hemorrhage: A Case Report.

Authors:  Sang-Hee Lee; Jeong-Hwan Seo; Sung-Hee Park; Yu Hui Won; Myoung-Hwan Ko
Journal:  Ann Rehabil Med       Date:  2015-08-25

2.  Terson's Syndrome - case report.

Authors:  Andreea Moraru; Ruxandra Mihailovici; Dănuţ Costin; Daniel Brănişteanu
Journal:  Rom J Ophthalmol       Date:  2017 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.